Neuroprotective effects of 2,5-diaryl-3,4-dimethyltetrahydrofuran neolignans

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 2, 2005, Pages 289-293

  Zhai, Haifeng ^a   Inoue, Takako ^a   Moriyama, Miyako ^a   Esumi, Tomoyuki ^a   Mitsumoto, Yasuhide ^b   Fukuyama, Yoshiyasu ^a  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

2,5 diaryl 3,4 dimethyltetrahydrofuran; Aristolochia arcuata; Neuroprotection; Neurotrophic effect; Primary cultured neuron

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 3,4 DIMETHYLTETRAHYDROFURAN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[25-35]; ARISTOLIGNIN; GALGRAVIN; ISONECTANDRIN B; NECTANDRIN; NEOLIGNAN; TALAUMIDIN; UNCLASSIFIED DRUG; VERAGUENSIN; FURAN DERIVATIVE; LIGNAN; NEUROPROTECTIVE AGENT; PLANT EXTRACT;

ANIMAL CELL; ARISTOLOCHIA; ARISTOLOCHIA ARCUATA; ARTICLE; CELL SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG ISOLATION; EMBRYO; HIPPOCAMPUS; NERVE CELL CULTURE; NERVE FIBER GROWTH; NEUROPROTECTION; NEUROTOXICITY; NEUROTROPISM; NONHUMAN; RAT; ANIMAL; CELL CULTURE; CHEMISTRY; DOSE RESPONSE; ISOLATION AND PURIFICATION; NERVE CELL; PHYSIOLOGY; PLANT ROOT; SPRAGUE DAWLEY RAT;

ANIMALS; ARISTOLOCHIA; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FURANS; LIGNANS; NEURONS; NEUROPROTECTIVE AGENTS; PLANT EXTRACTS; PLANT ROOTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 19444365400     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.289     Document Type: Article

References (28)

1. Mattson M. P., Nat. Rev. Mol. Cell Biol., 1, 120-129 (2000).
2. Citron M., Trends Pharmacol. Sci., 25, 92-97 (2004).
3. Taylor J. P., Hardy J., Fischbeck K. H., Science, 296, 1991-1995 (2002).
4. Buchmeier M. J., Lane T. E., Curr. Opin. Microbiol., 2, 398-402 (1999).
5. Reynish W., Andrieu S., Nourhashemi F., Vellas B., J. Gerontol. A Biol. Sci. Med. Sci., 56, M675-M680 (2001).
6. Price D. L., Sisodia S. S., Borchelt D. R., Science, 282, 1079-1083 (1998).
7. Delacourte A., Sergeant N., Buee L., Exp. Gerontol., 38, 1309-1317 (2003).
8. Vajda F. J., J. Clin. Neurosci., 9, 4-8 (2002).
9. Moosmann B., Behl C., Expert Opin. Investig. Drugs, 11, 1407-1435 (2002).
10. Martin A., Youdim K., Szprengiel A., Shukitt-Hale B., Joseph J., Nutr. Rev., 60, 308-326 (2002).
11. Beal M. F., Methods Enzymol., 382, 473-487 (2004).
12. Dawbarn D., Allen S. J., Neuropathol. Appl. Neurobiol., 29, 211-230 (2003).
13. Pollack S. J., Harper S. J., Curr Drug Targets. CNS Neurol. Disord., 1, 59-80 (2002).
14. Zhai H., Nakatsukasa M., Mitsumoto Y., Fukuyama Y., Planta Med., 70, 598-602 (2004).
15. Pike C. J., Walencewicz-Wasserman A. J., Kosmoski J., Cribbs D. H., Glabe C. G., Cotman C. W., J. Neurochem., 64, 253-265 (1995).
16. Collier T. J., Steece-Collier K., McGuire S., Sortwell C. E., Ann. N.Y. Acad. Sci., 991, 140-151 (2003).
17. Vieira L. M., Kijjoa A., Silva A. M. S., Mondranondra I. O., Herz W., Phytochemistry, 48, 1079-1081 (1998).
18. Barata L. E. S., Baker P. M., Gottlieb O. R., Ruveda E. A., Phytochemistry, 17, 783-786 (1978).
19. Urzua A., Freyer A. J., Shamma M., Phytochemistry, 26, 1509-1511 (1987).
20. Le Quesne P. W., Larrahondo J. E., Raffauf R. F., J. Nat. Prod., 43, 353-359 (1980).
21. Hansen M. B., Nielsen S. E., Berg K., J. Immunol. Methods, 119, 203-210 (1989).
22. da Silva Filho A. A., Albuquerque S., Silva M. L., Eberlin M. N., Tomazela D. M., Bastos J. K., J. Nat. Prod., 67, 42-45 (2004).
23. Chen Z. N., Yu P. Z., Xu P. J., Zhongguo Zhong Yao Za Zhi, 18, 292-294, 318 (1993).
24. Ma C. J., Sung S. H., Kim Y. C., Planta Med., 70, 79-80 (2004).
25. Gomez C., Reiriz J., Pique M., Gil J., Ferrer I., Ambrosio S., J. Neurosci. Res., 63, 421-428 (2001).
26. Hartley A., Stone J. M., Heron C., Cooper J. M., Schapira A. H., J. Neurochem., 63, 1987-1990 (1994).
27. Leist M., Volbracht C., Fava E., Nicotera P., Mol. Pharmacol., 54, 789-801 (1998).
28. Gerlach M., Riederer P., J. Neural Transm., 103, 987-1041 (1996).